SCHEMBL23217992

SCHEMBL23217992

OB(O)c1c(-c2cccc(C(F)F)n2)nn2c1CCC2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 17/20 0.43
THRB P10828 13/20 0.43
MAPK14 Q16539 7/20 0.43
TGFBR2 P37173 3/20 0.35
MAP3K20 Q9NYL2 2/20 0.35
CYP2D6 P10635 1/20 0.35
GAK O14976 1/20 0.33
RIPK2 O43353 1/20 0.33
MAP4K4 O95819 1/20 0.33
KDR P35968 1/20 0.33
ACVR1B P36896 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CSNK1D P48730 1/20 0.33
CSNK1E P49674 1/20 0.33
TGFB2 P61812 1/20 0.33
MINK1 Q8N4C8 1/20 0.33
COQ8A Q8NI60 1/20 0.33
TNIK Q9UKE5 1/20 0.33
RIPK3 Q9Y572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3949903 0.81 TGFBR1 (0.62) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL23217907 0.81 TGFBR1 (0.45) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL3941021 0.76 THRB (0.57) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL3942578 0.73 THRB (0.53) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL19732293 0.71 THRB (0.58) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL20893668 0.70 TGFBR1 (0.44) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL28938616 0.64 TGFBR1 (0.70) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL22561233 0.64 TGFBR1 (0.68) TGFBR1THRBMAPK14TGFBR2MAP3K20
SCHEMBL23217949 0.62 TGFBR1 (0.66) TGFBR1THRBMAPK14
SCHEMBL19732288 0.62 TGFBR1 (0.65) TGFBR1THRBMAPK14TGFBR2MAP3K20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076905-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-04-14 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed